Now showing items 1-3 of 3

    • Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana 

      Toledo, Lauren; McLellan-Lemal, Eleanor; Henderson, Faith L.; Kebaabetswe, Poloko M. (Scientific Research, 2015-03)
      Recent clinical trials have shown that a daily dose of oral TDF/FTC pre-exposure prophylaxis (PrEP) is effective in reducing human immunodeficiency (HIV) risk. Understanding trial participants’ perspectives about retention ...
    • Metabolic Syndrome in People with HIV/AIDS 

      Werberich, Ana Paula; Ceren, Juliana; Romancini, Jayder L. H.; Pimentel, Giuliano G. de A.; Junior, Miguel S.; Pupulin, Áurea R. T. (Scientific Research, 2013-12)
      Background: Highly Active Antiretroviral Therapy (HAART) has changed the clinical picture of HIV infection by reducing morbidity and mortality rates in the population. However, alterations in lipid metabolism leading to ...
    • New-Onset Seizures in HIV Patients on Antiretroviral Therapy at a Tertiary Centre in South-West, Nigeria 

      Olajumoke, Oshinaike; Akinsegun, Akinbami; Njideka, Okubadejo; Oluwadamilola, Ojo; Olaitan, Ojelabi; Adedoyin, Dosunmu; Adewumi, Adediran; Akinola, Dada; Sarah, Ajibola (Scientific Research, 2013-06)
      Background: Seizures are associated with neurological manifestations of HIV. They may be the presenting symptom and can occur at any disease stage. Aim: To determine the frequency and clinical aspects of new-onset seizures ...